Lomond Therapeutics
- Business Model
- B2B
- Website
- lomondther.com
- Total Funding
- $64.0M
- Last Round
- $20.0M Venture RoundMar 2025
- Rounds
- 2
About
Precision hematology company discovering and developing small molecule inhibitors targeting escape variants in hematologic malignancies.
Summary
Lomond Therapeutics is a Biotech company. It has raised $64.0M in total across 2 rounds, most recently a $20.0M Venture Round round in Mar 2025. Investors include Yosemite, Deerfield Management Company and OrbiMed.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company